Figure 4

Cumulative (A) overall and (B) recurrence-free survival curves of the combination of intratumoral mutant p53 and cavin-1 expression and (C, D) their validation. Patients with the combination of mutant p53 status and strong cavin-1 expression (group III) had the shortest survival after resection of PDAC.